Positron emission tomography after fetal transplantation in Huntington's disease

Sarah Furtado, Vesna Sossi, Roberta A. Hauser, Ali Samii, Michael Schulzer, Colleen B. Murphy, Thomas B. Freeman, A. Jon Stoessl

Annals of Neurology · 2005 · 64 citations · 8 references

Concepts

Abstract

Huntington's disease (HD) is a progressive disorder with no known cure. We report two-year postoperative positron emission tomography (PET) data from 7 HD patients who underwent intrastriatal fetal transplantation. Patients showed widespread reductions in glucose uptake with no significant change over 2 years. Dopamine receptor binding was significantly reduced in HD striatum. D1 binding did not change significantly following transplantation, but there was a significant loss of D2 binding. These findings may reflect loss of graft viability and/or disease progression. There was no significant relationship between changes in PET and clinical function. In summary, there was no benefit from transplantation.

References

8